15516786

Kilic-Okman T

2004

Relationship between homocysteine and insulin resistance in women with polycystic ovary syndrome.

15517078

Meenakumari KJ

2004

Effects of metformin treatment on luteal phase progesterone concentration in polycystic ovary syndrome.

15523185

Hashemipour M

2004

Prevalence of polycystic ovary syndrome in girls aged 14-18 years in Isfahan, Iran.

15523856

Siminialayi IM

2004

Glucocorticoids and the insulin resistance syndrome.

15524424

Olszanecka-Glinianowicz M

2004

[Sibutramine administration in polycystic ovary syndrome treatment].

15526505

Tankova T

2003

Current indications for metformin therapy.

15526714

Long DN

2004

Gender role across development in adult women with congenital adrenal hyperplasia due to 21-hydroxylase deficiency.

15526717

Teixeira RJ

2004

Serum leptin levels in premature pubarche and prepubertal girls with and without obesity.

15526718

Noczy?ska A

2004

Hyperprolactinemia in children during the peripubertal period--personal observations.

15527637

Gonzalez R

2004

Management of incidental ovarian tumors in patients undergoing gastric bypass.

15528263

Le Du A

2005

In vitro oocyte maturation for the treatment of infertility associated with polycystic ovarian syndrome: the French experience.

15531122

Somboonporn W

2004

Postmenopausal testosterone therapy and breast cancer risk.

15531477

Maciel GA

2004

Stockpiling of transitional and classic primary follicles in ovaries of women with polycystic ovary syndrome.

15531497

Talbott EO

2004

Evidence for an association between metabolic cardiovascular syndrome and coronary and aortic calcification among women with polycystic ovary syndrome.

15531511

Yildiz BO

2004

Stability of adrenocortical steroidogenesis over time in healthy women and women with polycystic ovary syndrome.

15531516

Tarkun I

2004

Endothelial dysfunction in young women with polycystic ovary syndrome: relationship with insulin resistance and low-grade chronic inflammation.

15531721

Quinkler M

2004

Androgen generation in adipose tissue in women with simple obesity--a site-specific role for 17beta-hydroxysteroid dehydrogenase type 5.

15533359

Agrawal R

2004

Prevalence of polycystic ovaries and polycystic ovary syndrome in lesbian women compared with heterosexual women.

15533360

J?rvel? IY

2004

Comparison of follicular vascularization in normal versus polycystic ovaries during in vitro fertilization as measured using 3-dimensional power Doppler ultrasonography.

15533361

Erturk E

2004

Serum leptin levels correlate with obesity parameters but not with hyperinsulinism in women with polycystic ovary syndrome.

15533381

Gulekli B

2004

Randomized, controlled trial of priming with 10,000 IU versus 20,000 IU of human chorionic gonadotropin in women with polycystic ovary syndrome who are undergoing in vitro maturation.

15533384

Xita N

2004

A polymorphism in the resistin gene promoter is associated with body mass index in women with polycystic ovary syndrome.

15534444

Lord J

2004

Metformin in polycystic ovary syndrome.

15535111

Lazurova I

2004

Metformin versus sibutramine in the treatment of hyperinsulinemia in chronically anovulating women.

15536162

Jayagopal V

2005

Orlistat is as beneficial as metformin in the treatment of polycystic ovarian syndrome.

15539436

Rice S

2005

Impaired insulin-dependent glucose metabolism in granulosa-lutein cells from anovulatory women with polycystic ovaries.

15542929

Bahceci M

2004

Serum C-reactive protein (CRP) levels and insulin resistance in non-obese women with polycystic ovarian syndrome, and effect of bicalutamide on hirsutism, CRP levels and insulin resistance.

15547527

Carmina E

2004

Does metformin induce ovulation in normoandrogenic anovulatory women?

15548396

Aruna J

2004

Metformin therapy in women with polycystic ovary syndrome.

15548403

Giordano MG

2004

Immunohistochemical analysis of IGF-1 and IGF-2 receptors in ovaries of patients with polycystic ovary syndrome.

15550333

Kodaman PH

2004

Hormonal regulation of implantation.

15554139

Karlov VA

2004

[Therapy of epilepsy: current strategy and tactics].

15557546

Kaplan PW

2004

Reproductive health effects and teratogenicity of antiepileptic drugs.

15559352

Fernandez H

2004

Fertility after ovarian drilling by transvaginal fertiloscopy for treatment of polycystic ovary syndrome.

15561799

Escobar-Morreale HF

2005

The molecular-genetic basis of functional hyperandrogenism and the polycystic ovary syndrome.

15562389

Goldenberg N

2005

Metformin-diet benefits in women with polycystic ovary syndrome in the bottom and top quintiles for insulin resistance.

15567683

Cr?quat J

2004

[Endorectal sonography in gynecology: usefulness and diagnostic accuracy].

15570986

Veening MA

2004

Pubertal development in children born small for gestational age.

15576394

Cibula D

2005

The effect of combination therapy with metformin and combined oral contraceptives (COC) versus COC alone on insulin sensitivity, hyperandrogenaemia, SHBG and lipids in PCOS patients.

15579189

Spranger J

2004

Adiponectin is independently associated with insulin sensitivity in women with polycystic ovary syndrome.

15579328

Armanini D

2004

Licorice reduces serum testosterone in healthy women.

15579759

Talbott EO

2004

The relationship between C-reactive protein and carotid intima-media wall thickness in middle-aged women with polycystic ovary syndrome.

15579780

Bruns CM

2004

Insulin resistance and impaired insulin secretion in prenatally androgenized male rhesus monkeys.

15587140

Saleh HA

2004

Serum leptin elevation in obese women with PCOs: a continuing controversy.

15587142

Fuchinoue K

2004

Successful pregnancy and delivery following combined treatment of in vitro maturation (IVM) and testicular sperm extraction (TESE): a case report.

15588465

Gerli S

2004

Ovulation induction with urinary FSH or recombinant FSH in polycystic ovary syndrome patients: a prospective randomized analysis of cost-effectiveness.

15588467

Orio F Jr

2004

Is plasminogen activator inhibitor-1 a cardiovascular risk factor in young women with polycystic ovary syndrome?

15589862

Glintborg D

2004

Prevalence of endocrine diseases and abnormal glucose tolerance tests in 340 Caucasian premenopausal women with hirsutism as the referral diagnosis.

15589878

Chian RC

2004

Natural-cycle in vitro fertilization combined with in vitro maturation of immature oocytes is a potential approach in infertility treatment.

15589886

Escobar-Morreale HF

2004

Macroprolactinemia in women presenting with hyperandrogenic symptoms: Implications for the management of polycystic ovary syndrome.

15590747

Xita N

2005

Effect of adiponectin gene polymorphisms on circulating adiponectin and insulin resistance indexes in women with polycystic ovary syndrome.

15592272

Souter I

2004

The prevalence of androgen excess among patients with minimal unwanted hair growth.

15596265

Doi SA

2005

PCOS: an ovarian disorder that leads to dysregulation in the hypothalamic-pituitary-adrenal axis?

15598674

Ortega-Gonz?lez C

2005

Responses of serum androgen and insulin resistance to metformin and pioglitazone in obese, insulin-resistant women with polycystic ovary syndrome.

15598676

Wickenheisser JK

2005

Dysregulation of cytochrome P450 17alpha-hydroxylase messenger ribonucleic acid stability in theca cells isolated from women with polycystic ovary syndrome.

15598692

Glintborg D

2005

Significantly higher adrenocorticotropin-stimulated cortisol and 17-hydroxyprogesterone levels in 337 consecutive, premenopausal, caucasian, hirsute patients compared with healthy controls.

15598698

Ciampelli M

2005

Assessment of insulin sensitivity from measurements in the fasting state and during an oral glucose tolerance test in polycystic ovary syndrome and menopausal patients.

15598877

Wood JR

2005

Valproate-induced alterations in human theca cell gene expression: clues to the association between valproate use and metabolic side effects.

15604534

Salvetti NR

2004

Expression of cytoskeletal proteins in the follicular wall of induced ovarian cysts.

15605090

Hu ZX

2004

[The differential expression profile of polycystic ovary syndrome associated genes].

15605768

Vishnevskaia EE

2004

[Peculiar relationships between endometrial carcinoma and body in young women].

15608032

Bahceci M

2005

Does underlying infertility aetiology impact on first trimester miscarriage rate following ICSI? A preliminary report from 1244 singleton gestations.

15613682

Corbould A

2005

Insulin resistance in the skeletal muscle of women with PCOS involves intrinsic and acquired defects in insulin signaling.

15614192

Kucuk M

2005

Hormone profiles and clinical outcome after laparoscopic ovarian drilling in women with polycystic ovary syndrome.

15615020

Liu HK

2004

Effect of chronic progesterone injection on egg production in Japanese quail.

15615216

Olson KK

2004

Acanthosis nigricans. A guide to assessment and evaluation.

15617954

Guyatt G

2004

Health-related quality of life in women with polycystic ovary syndrome, a self-administered questionnaire, was validated.

15618250

Kilicdag EB

2005

Homocysteine levels in women with polycystic ovary syndrome treated with metformin versus rosiglitazone: a randomized study.

15623819

Apridonidze T

2005

Prevalence and characteristics of the metabolic syndrome in women with polycystic ovary syndrome.

15624268

Turkmen S

2004

Reduction of dehydroepiandrosterone sulfate synthesis in women with polycystic ovary syndrome by human menopausal gonadotropin but not purified urinary follicle stimulating hormone: a comparative pilot study.

15624269

Hirschberg AL

2004

Impaired cholecystokinin secretion and disturbed appetite regulation in women with polycystic ovary syndrome.

15624270

Santana LF

2004

Effect of metformin on the clinical and metabolic assessment of women with polycystic ovary syndrome.

15625771

Lam PM

2004

Revisit of metformin treatment in polycystic ovarian syndrome.

15628689

Smith DO

2004

Insulin resistance syndrome, pre-diabetes, and the prevention of type 2 diabetes mellitus.

15634726

Raskauskiene D

2005

Do polycystic ovaries on ultrasound scan indicate decreased insulin sensitivity in sisters of women with polycystic ovary syndrome?

15636438

Palomba S

2004

Is ovulation induction still a therapeutic problem in patients with polycystic ovary syndrome?

15637992

Puziga?a S

2001

[Sertoli-Leydig cell tumour (arrhenoblastoma) in a patient with polycystic ovary syndrome: clinical, ultrasonographic, hormonal and histopathological evaluation].

15638392

Dzienis A

2004

Adrenergic innervation and steroidogenic activity of cystic porcine ovaries.

15638868

Diamanti-Kandarakis E

2005

Increased levels of serum advanced glycation end-products in women with polycystic ovary syndrome.

15640251

Akman MA

2005

Endometrial fluid visualized through ultrasonography during ovarian stimulation in IVF cycles impairs the outcome in tubal factor, but not PCOS, patients.

15640254

van Wely M

2005

Predictors for treatment failure after laparoscopic electrocautery of the ovaries in women with clomiphene citrate resistant polycystic ovary syndrome.

15641698

Lv L

2004

Effect of rosiglitazone on endocrine, metabolism and ovulatory performance in patients with polycystic ovary syndrome and insulin resistance.

15642799

Ortega-Gonz?lez C

2005

Insulin sensitizing drugs increase the endogenous dopaminergic tone in obese insulin-resistant women with polycystic ovary syndrome.

15644405

Mehta RV

2005

Luteinizing hormone secretion is not influenced by insulin infusion in women with polycystic ovary syndrome despite improved insulin sensitivity during pioglitazone treatment.

15644580

Bayraktar F

2004

Plasma homocysteine levels in polycystic ovary syndrome and congenital adrenal hyperplasia.

15649101

Lara MD

2005

Surgical management of obesity: a review of the evidence relating to the health benefits and risks.

15651230

Aradhana R

2004

Estrogen receptor alpha gene PvuII polymorphism and polycystic ovary syndrome.

15652898

Fleming R

2005

Metformin reduces serum mullerian-inhibiting substance levels in women with polycystic ovary syndrome after protracted treatment.

15652919

Panidis D

2005

Decrease in adiponectin levels in women with polycystic ovary syndrome after an oral glucose tolerance test.

15653205

Mitkov M

2005

Combined use of metformin and ethinyl estradiol-cyproterone acetate in polycystic ovary syndrome.

15653207

Abd El Aal DE

2005

Vascular endothelial growth factor and insulin-like growth factor-1 in polycystic ovary syndrome and their relation to ovarian blood flow.

15663918

Svatikova A

2005

Interactions between obstructive sleep apnea and the metabolic syndrome.

15664293

Mahmutyazicio?lu K

2005

Transabdominal pulse inversion harmonic imaging improves assessment of ovarian morphology in virgin patients with PCOS: comparison with conventional B-mode sonography.

15665022

Ertunc D

2005

The importance of IRS-1 Gly972Arg polymorphism in evaluating the response to metformin treatment in polycystic ovary syndrome.

15670186

P?rez-Bravo F

2005

Tryptophan 64 --> arginine polymorphism of beta-3-adrenergic receptor in Chilean women with polycystic ovary syndrome.

15670405

Battaglia C

2004

Ultrasound evaluation of PCO, PCOS and OHSS.

15670668

McClain CJ

2004

Mechanisms of non-alcoholic steatohepatitis.

15673641

McCook JG

2005

Health-related quality of life issues in women with polycystic ovary syndrome.

15674894

Beck JI

2005

Oral anti-oestrogens and medical adjuncts for subfertility associated with anovulation.

15677534

Bickerton AS

2005

Cardiovascular risk in women with polycystic ovarian syndrome (PCOS).